ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 83 filers reported holding ENZO BIOCHEM INC in Q1 2021. The put-call ratio across all filers is 4.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $819,000 | -62.7% | 237,992 | -72.7% | 0.01% | -68.0% |
Q4 2020 | $2,195,000 | +25.1% | 871,112 | +4.8% | 0.02% | 0.0% |
Q3 2020 | $1,754,000 | +18.8% | 831,092 | +26.1% | 0.02% | +13.6% |
Q2 2020 | $1,477,000 | -32.9% | 659,316 | -24.2% | 0.02% | -43.6% |
Q1 2020 | $2,201,000 | -13.3% | 870,079 | -9.9% | 0.04% | +21.9% |
Q4 2019 | $2,539,000 | -31.3% | 965,584 | -5.9% | 0.03% | -34.7% |
Q3 2019 | $3,695,000 | +238.7% | 1,026,313 | +217.1% | 0.05% | +250.0% |
Q2 2019 | $1,091,000 | – | 323,615 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBERT FUND ADVISORS, INC. | 5,175,913 | $7,246,278 | 5.30% |
Potomac Capital Management, Inc. | 1,455,000 | $2,037,000 | 2.60% |
TANG CAPITAL MANAGEMENT LLC | 2,200,000 | $3,080,000 | 0.44% |
RBF Capital, LLC | 250,359 | $350,503 | 0.02% |
KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $36,000 | 0.02% |
Shay Capital LLC | 62,500 | $87,500 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 227,100 | $317,940 | 0.01% |
Paradigm Financial Partners, LLC | 19,500 | $26,325 | 0.01% |
Shulman DeMeo Asset Management LLC | 15,487 | $21,682 | 0.01% |
Renaissance Technologies | 2,556,064 | $3,578 | 0.01% |